Damage Evaluation in the pharmaceutical industry

The period immediately preceding the termination of distribution agreements between manufacturers and distributors, usually long-term lasting, represents a critical moment in the relationships between the parts, especially considering the possible renewal. During these phases the risk of litigation increases and often leads to damage refund claims due to contractual infringements.

Competence Area:

Litigation and damage estimation

Industry:

Pharma & Health Care

Economic appraisal for a producer of an oncologic drug

Development of an economic appraisal aimed at estimating the alleged damage suffered by a producer of an oncologic drug, because of the breach of the distributorship agreement by the Italian distributor of such drug

Competence Area:

Litigation and damage estimation

Industry:

Pharma & Health Care